FY2025 · ended Dec 31, 2025 · Revenue $5.04B, +0.9% YoY · Filed Feb 18, 2026
Herbalife Ltd. (HLF) files with the SEC under industry code 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $5.0 billion and net income of $228.3 million. Free cash flow was $252.9 million. As of Sep 30, 2026 it held $409.2 million in cash and investments and $2.1 billion in total debt.
Revenue (TTM)
$5.28B
+6.4% vs year-ago TTM
Net income (TTM)
$179.80M
-44.0% vs year-ago TTM
Operating cash flow (TTM)
$396.30M
+30.1% vs year-ago TTM
Free cash flow (TTM)
$337.10M
+55.3% vs year-ago TTM
EPS (TTM)
$1.68
-46.1% vs year-ago TTM
Dividend per share
$1.20
+0.0% vs prior year
Shares outstanding
103.37M
+2.1% vs prior year
Net cash
$-1.70B
as of Sep 30, 2026
Operating margin
9.6%
FY 2026
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- HLF (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- George Town, Cayman Islands
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1180262
- Former names
- HERBALIFE NUTRITION LTD. (until Apr 11, 2023); WH HOLDINGS CAYMAN ISLANDS LTD (until Dec 13, 2004)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- DataMeds AI, Inc. MEDS
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $5.0B | $5.0B | $5.1B | $5.2B | $5.8B |
| Operating income | $481.0M | $385.9M | $356.4M | $545.2M | $734.1M |
| Net income | $228.3M | $254.3M | $142.2M | $321.3M | $447.2M |
| Diluted EPS | $2.20 | $2.50 | $1.42 | $3.23 | $4.13 |
| Operating cash flow | $333.3M | $285.4M | $357.5M | $352.5M | $460.3M |
| Free cash flow | $252.9M | $163.4M | $222.5M | $196.1M | $308.9M |
| Total assets | $2.8B | $2.7B | $2.8B | $2.7B | $2.8B |
| Total liabilities | $3.3B | $3.5B | $3.9B | $4.0B | $4.2B |
| Stockholders' equity | -$515.1M | -$801.1M | -$1.1B | -$1.3B | -$1.4B |
| Cash and investments | $353.1M | $415.3M | $575.2M | $508.0M | $601.5M |
| Total debt | $2.2B | $2.5B | $2.8B | $2.9B | $3.0B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 2, 2026 | Nov 2, 2026 |
| 10-Q | Quarterly report | Nov 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 31, 2026 | Aug 25, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Aug 5, 2026 | Jul 30, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Shareholder vote results, Regulation FD disclosure
|
May 6, 2026 | Apr 30, 2026 |
All 1003 Herbalife Ltd. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.